Ads
related to: metastatic renal cell carcinoma- Treatment Guide
Download A Treatment
Management Guide Today.
- Contact A Rep
Contact A Representative To Get
More Info About A Treatment Option.
- 1L Monotherapy
Find Information On The Study
Design And 1L Efficacy & Safety.
- Co-Pay Information
Learn More About A Co-Pay Program
For Eligible aRCC Patients.
- Dosing & Admin Guide
Download A Dosing Guide To Find
The Right Dose For Your Patients.
- Efficacy & Safety Info
View Efficacy & Safety Information
For An aRCC Treatment Option.
- Treatment Guide
Search results
Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments
GuruFocus.com via Yahoo Finance· 3 months agoExelixis Inc. (NASDAQ:EXEL) is a pharmaceutical company headquartered in Alameda, California that...
Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data
Zacks via Yahoo Finance· 6 months agoIt was a busy week for the biotech sector, with numerous study readouts and other updates. Quite a...
Will Keytruda & Gardasil Aid Merck (MRK) Sales in Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor, Keytruda,...
7 Myths About Kidney Cancer, Debunked
Time via Yahoo News· 1 year agodoctor holding orange ribbon. campaign to prevent skin cancer, melanoma, December orange Credit - Leonidas Santana—Getty Images Kidney cancer may well be...
Iovance (IOVA) Posts Narrower-Than-Expected Loss in Q2
Zacks via Yahoo Finance· 10 months agoIovance Biotherapeutics, Inc. IOVA incurred a loss of 47 cents per share in second-quarter 2023,...
Is Exelixis' (EXEL) Growth Story Likely to Continue?
Zacks via Yahoo Finance· 2 years agoExelixis EXEL, an oncology-focused company, maintains momentum on the back of the solid performance of its lead drug Cabometyx amid stiff competition...
Is Kidney Cancer Curable? Understanding the Odds
Verywell Health via Yahoo News· 5 months agoThere are several types of kidney (renal) cancer. Each type is potentially curable if it's found and treated early, before the cancer has a chance to...
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Benzinga via Yahoo Finance· 1 year agoExelixis Inc (NASDAQ: EXEL) announced that the phase 3 CONTACT-03 study did not meet its primary...
Merck (MRK), Eisai Combo Therapy Fail Two Lung Cancer Studies
Zacks via Yahoo Finance· 8 months agoData from both late-stage studies evaluating Merck's (MRK) Keytruda and Eisai's Lenvima combination...
Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study
Zacks via Yahoo Finance· 6 months agoExelixis, Inc. EXEL entered into a clinical collaboration with clinical-stage company Arcus...
Ads
related to: metastatic renal cell carcinoma